Diaceutics PLC (AIM:DXRX)
London · Delayed Price · Currency is GBP · Price in GBX 193.00
0.00 (0.00%)
Sep 25, 2026, 4:41 PM GMT
Diaceutics Market Cap
Diaceutics has a market cap or net worth of 163.83 million as of September 25, 2026. Its market cap has increased by 21.00% in one year.
Market Cap
163.83M
Enterprise Value
157.82M
Revenue
41.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
193.00
ChartMarket Cap Chart
Since March 21, 2019, Diaceutics's market cap has increased from 66.45M to 163.83M, an increase of 146.54%. That is a compound annual growth rate of 12.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 163.83M | 50.73% |
| Dec 31, 2025 | 108.69M | 2.47% |
| Dec 31, 2024 | 106.07M | 44.67% |
| Dec 29, 2023 | 73.32M | 15.14% |
| Dec 30, 2022 | 63.68M | -25.74% |
| Dec 31, 2021 | 85.75M | -23.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Craneware | 342.16M |
| Optima Health | 267.59M |
| MedPal AI | 50.91M |
| Renalytix | 37.14M |
| Cambridge Cognition Holdings | 13.04M |
| Feedback | 2.78M |
| Imaging Biometrics | 2.22M |
| Trellus Health | 172.05K |